Skip to main content

Table 1 Effect of Angelica Sinensis on viability of myotubes (%)

From: Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway

   Concentration of Angelica Sinensis treatment (ng/mL)
Control 1 10 102 103 104 105 106
24 h 100.00 ± 3.53 99.45 ± 4.09 99.89 ± 5.64 98.18 ± 4.52 93.94 ± 6.59 91.24 ± 4.34 83.62 ± 5.07* 74.41 ± 5.88*
48 h 100.00 ± 3.42 100.15 ± 5.34 100.04 ± 5.56 100.13 ± 5.75 93.49 ± 4.44 91.22 ± 4.09 75.08 ± 5.15* 68.82 ± 4.65*
72 h 100.00 ± 3.75 98.56 ± 3.49 99.42 ± 5.21 99.17 ± 4.86 91.31 ± 3.92 90.64 ± 3.59 74.93 ± 5.26* 68.45 ± 4.53*
  1. Values are mean ± SD (n = 4). Data were analyzed with one-way ANOVA with dose factors. *Significantly different compared with the control at the same time of culture (Scheffe’s post hoc analysis, P < 0.05).